Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non–Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference31 articles.
1. Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.;Jensen;Am Heart J,2015
2. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.;Engstrøm;Lancet,2015
3. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial.;Gershlick;J Am Coll Cardiol,2015
4. Randomized trial of preventive angioplasty in myocardial infarction.;Wald;N Engl J Med,2013
5. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up.;Politi;Heart,2010
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Silent Myocardial Ischemia in Patients after Permanent Coronary Intervention;The Russian Archives of Internal Medicine;2022-05-20
2. Analysis on the Expression and Prognostic Value of LncRNA FAF in Patients with Coronary Heart Disease;BioMed Research International;2020-11-02
3. Tai Chi Improves Coronary Heart Disease Risk by Inactivating MAPK/ERK Pathway through Serum miR-126;Evidence-Based Complementary and Alternative Medicine;2020-04-26
4. Silent myocardial ischemia in patients after emergency coronary intervention (literature reviev);REV LATINOAM HIPERTE;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3